SETTLEMENT AND CROSS LICENSE AGREEMENTSettlement and Cross License Agreement • January 27th, 2014 • Insulet Corp • Surgical & medical instruments & apparatus • Delaware
This Settlement and Cross License Agreement (hereinafter, the “Agreement”), effective as of September 18, 2013 (hereinafter, the “Effective Date”), is made by and among Insulet Corporation, a Delaware corporation having its principal office at 9 Oak Park Dr., Bedford, MA, 01730 (hereinafter, “Insulet”), Medtronic Inc., a Minnesota corporation having its principal office at 710 Medtronic Parkway, Minneapolis, MN 55432-5604 (hereinafter, “Medtronic”), Medtronic MiniMed Inc., a Delaware corporation having its principal office at 18000 Devonshire Street, Northridge, CA 91325 (hereinafter, “MiniMed”), Medtronic Puerto Rico Operations Co., a corporation organized under the laws of the Cayman Islands (hereinafter, “MPROC”), and MiniMed Distribution Corp., a Delaware corporation having its principal office at 18000 Devonshire Street, Northridge, CA 91325 (hereinafter “MDC”). Insulet, Medtronic, MiniMed, MPROC and MDC are each hereinafter referred to individually as a “Party”, and collectively
SETTLEMENT AND CROSS LICENSE AGREEMENTSettlement and Cross License Agreement • September 13th, 2010 • MRV Communications Inc • Semiconductors & related devices • California
This Settlement and Cross License Agreement (this “Agreement”), effective as of September 10, 2010 (the “Effective Date”), is made and entered into by and among Finisar Corporation, a Delaware corporation with its principal place of business at 1389 Moffett Park Drive, Sunnyvale, California 94089-1134 (“Finisar”), on the one hand, and Source Photonics, Inc., a Delaware corporation with its principal place of business at 20550 Nordhoff Street, Chatsworth, California 91311 (“Source Photonics”), and MRV Communications, Inc., a Delaware corporation with its principal place of business at 20415 Nordhoff Street, Chatsworth, California 91311 (“MRV”) on the other hand (Finisar, Source Photonics, and MRV are collectively referred to as “the Parties” or individually as a “Party”).
Settlement and Cross License AgreementSettlement and Cross License Agreement • March 31st, 2010 • ALPHA & OMEGA SEMICONDUCTOR LTD • California
This Settlement and Cross License Agreement (this “Agreement”), effective as of the 17th day of October, 2008 (the “Effective Date”), is made and entered into between Fairchild Semiconductor Corporation, a corporation incorporated under the laws of Delaware and having a principal place of business at 82 Running Hill Road, South Portland, ME 04106, Fairchild Semiconductor International, Inc., a corporation incorporated under the laws of Delaware, and their Subsidiaries (collectively “Fairchild”) on the one hand; and Alpha & Omega Semiconductor, Inc., a corporation incorporated under the laws of California and having a principal place of business at 495 Mercury Drive, Sunnyvale, CA 94085, and Alpha & Omega Semiconductor, Ltd., a corporation incorporated under the laws of Bermuda, and their Subsidiaries (collectively “AOS”) on the other hand (each a “party” and collectively the “parties”).
SETTLEMENT AND CROSS-LICENSE AGREEMENT January 2, 2007Settlement and Cross-License Agreement • May 10th, 2007 • Cepheid • Laboratory analytical instruments • Idaho
This Settlement and Cross-License Agreement (this “Agreement”) is made and entered into between and among Idaho Technology, Inc. (“Idaho Technology”); the University of Utah Research Foundation (“Utah Research Foundation”); and Cepheid, a California corporation (“Cepheid”) as of the date first set forth above.
AMENDMENT NO. 1 TO SETTLEMENT AND CROSS-LICENSE AGREEMENTSettlement and Cross-License Agreement • May 10th, 2004 • Tanox Inc • Pharmaceutical preparations • New York
This Amendment (“Amendment”), effective as of February 25, 2004 (the “Amendment Effective Date”) is made by and between Genentech, Inc. (“Genentech”), a Delaware corporation having a principal place of business at 1 DNA Way, South San Francisco, California 94080, and Tanox, Inc. (formerly known as Tanox Biosystems, Inc.), originally a Texas corporation and reincorporated as a Delaware corporation (“Tanox”), with its principal offices at 10301 Stella Link, Houston, Texas 77025.
ContractSettlement and Cross License Agreement • May 5th, 2020 • California
<DOCUMENT> <TYPE>EX-10.27 <SEQUENCE>3 <FILENAME>a03028exv10w27.txt <DESCRIPTION>EXHIBIT 10.27 <TEXT> <PAGE> Exhibit 10.27 SETTLEMENT AND CROSS LICENSE AGREEMENT This is a Settlement and Cross License Agreement (the "Agreement"), effective as of August 18, 2004 (the "Effective Date"), by and between (1) Applera Corporation, a Delaware Corporation having its principal place of business at 301 Merritt 7, P.O. Box 5435, Norwalk, Connecticut 06856-5435, and all of its affiliates, divisions, and Affiliates (as defined in Article I of this Agreement), including but not limited to Applera Corporation - Applied Biosystems Group, an operating group of Applera Corporation, having its principal place of business at 850 Lincoln Centre Drive, Foster City, California 94404 (collectively, Applera Corporation and all of its affiliates and Affiliates are "Applera"); and (2) Illumina, Inc., having its principal place of business at 9885 Towne Centre Drive, San Diego, California 92121-1975, and all of its
